Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells

PurposeContinuous reductions in trabecular meshwork (TM) cellularity inhibit aqueous humor (AH) outflow, which is the main cause of primary open-angle glaucoma. Rho-associated protein kinase inhibitor (ROCKi) targets the TM to reduce intraocular pressure (IOP) and increase AH outflow facility. Howev...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Wenshi Chen, Xuejiao Yang, Jingwang Fang, Yuqing Zhang, Wei Zhu, Xian Yang
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2020-03-01
Reeks:Frontiers in Pharmacology
Onderwerpen:
Rho-associated protein kinase inhibitor
glaucoma
trabecular meshwork
proliferation
phagocytosis
Online toegang:https://www.frontiersin.org/article/10.3389/fphar.2020.00302/full
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items